Skip to Main Content

Paper Details

NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.
NPJ Breast Cancer
9
2019
Author NameAffiliation
Dirce Maria CarraroA.C. Camargo Cancer Center
Raphael B Parmigiani2Ludwig Institute for Cancer Research (LICR)
Roger ChammasInstituto do Cancer do Estado de Sao Paulo
Anamaria A CamargoHospital Sirio-Libanes
Anamaria A Camargo2Ludwig Institute for Cancer Research (LICR)
  • 1 - 5

Datasets

Release 1.2